NDAORALSYRUP
Approved
Jan 1965
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
3/8 — Basic
Drug data last refreshed 2h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Mestinon (pyridostigmine bromide) is an oral acetylcholinesterase inhibitor approved in 1965 for treating myasthenia gravis and related neuromuscular disorders. It works by inhibiting the breakdown of acetylcholine, thereby increasing neurotransmitter availability at the neuromuscular junction. The syrup formulation enables flexible dosing for patients with difficulty swallowing.
$7MPart D
LOE ApproachingWith LOE approaching and modest Part D spending (~$7M), the brand team is likely small and focused on defending market position against generics and new entrants.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Testing Mestinon and Exercise in Fibromyalgia
Started Sep 2002
178 enrolled
Fibromyalgia
Career Relevance
Working on Mestinon as it approaches LOE offers limited career growth but valuable experience in lifecycle management, generic competition strategy, and defending legacy products. Roles are primarily commercial and field-focused, with minimal expansion opportunity.
Brand Manager
Worked on MESTINON at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.